References
- Joy PS, Kumar G, et al. Cardiac implantable electronic device
infections: who is at greatest risk? Heart Rhythm 2017;14:839–45.
- Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC,
Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM,
Saghy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N; ESC
Scientific Document Group. European Heart Rhythm Association (EHRA)
international consensus document on how to prevent, diagnose, and
treat cardiac implantable electronic device infections-endorsed by the
Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society
(APHRS), the Latin American Heart Rhythm Society (LAHRS),
International Society for Cardiovascular Infectious Diseases (ISCVID)
and the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) in collaboration with the European Association for
Cardio-Thoracic Surgery (EACTS). Europace. 2020 Apr 1;22(4):515-549
- El-Chami MF, Al-Samadi F, et al. Updated performance of the Micra
transcatheter pacemaker in the real-world setting: A comparison to the
investigational study and a transvenous historical control. Heart
Rhythm. 2018 Dec;15(12):1800-1807. doi: 10.1016/j.hrthm.2018.08.005
- Chang D, Gabriels JK, et al. Concomitant leadless pacemaker
implantation and lead extraction during an active infection. J
Cardiovasc Electrophysiol. 2020 Apr;31(4):860-867.
- Kypta A, Blessberger H, Kammler J, Lambert T, Lichtenauer M,
Brandstaetter W, et al. Leadless cardiac pacemaker implantation after
lead extraction in patients with severe device infection. J Cardiovasc
Electrophysiol 2016;27:1067–71.
- Bicong, Li et al. “Leadless pacemaker implantation after lead
extraction for cardiac implanted electronic device
infection.” Journal of cardiovascular electrophysiology vol.
33,3 (2022): 464-470.
- Brunner MP, Cronin EM, et al. Outcomes of patients requiring emergent
surgical or endovascular intervention for catastrophic complications
during transvenous lead extraction. Heart Rhythm. 2014
Mar;11(3):419-25.